“I am honoured to be part of this ground-breaking clinical trial of EBV-specific T cell therapy in MS. My hope is that this treatment is safe, effective and ultimately transforms the face of MS treatment worldwide.”
Dr Zara Ioannides
Tomorrow’s breakthrough needs you today
If you would like to pledge a gift amount for annual support of the Multiple Sclerosis Research Group,
please contact Victoria Andrews – General Manager Supporter Impact
Email: victoria.andrews@msqld.org.au
Phone: (07) 3840 0874